✦ LIBER ✦

Re-evaluation of the efficacy of the association of cabergoline to somatostatin analogues in acromegalic patients

✍ Scribed by Gatta, Blandine ;Hau, Doan Huu ;Catargi, Bogdan ;Roger, Patrick ;Tabarin, Antoine

Book ID: 108703231
Publisher: John Wiley and Sons
Year: 2005
Tongue: English
Weight: 92 KB
Volume: 63
Category: Article
ISSN: 0300-0664
DOI: 10.1111/j.1365-2265.2005.02329.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Cabergoline addition to depot somatostat

Cabergoline addition to depot somatostatin analogues in resistant acromegalic patients: efficacy and lack of predictive value of prolactin status

✍ Renato Cozzi; Roberto Attanasio; Sandro Lodrini; Giovanni Lasio 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 133 KB

Role of the addition of cabergoline to t

Role of the addition of cabergoline to the management of acromegalic patients resistant to longterm treatment with octreotide LAR

✍ Lucio Vilar; Monalisa F. Azevedo; Luciana Ansaneli Naves; Luiz Augusto Casulari; 📂 Article 📅 2010 🏛 Springer US 🌐 English ⚖ 274 KB

Evaluation of the synthetic somatostatin

Evaluation of the synthetic somatostatin analogue SMS 201-995 in patients with hypoglycaemia associated with hepatocellular carcinoma

✍ Joffe, BI; Kew, MC; Panz, VR; Kalk, WJ; Shires, R; Wing, J; Seftel, HC 📂 Article 📅 1988 🏛 Nature Publishing Group 🌐 English ⚖ 388 KB

Efficacy and Tolerability of the Long-Ac

Efficacy and Tolerability of the Long-Acting Somatostatin Analog Lanreotide in Acromegaly. A 12-Month Multicenter Study of 58 Acromegalic Patients

✍ Philippe Chanson; Anne Leselbaum; Joelle Blumberg; Gilbert Schaison 📂 Article 📅 2000 🏛 Springer US 🌐 English ⚖ 115 KB

A phase III evaluation of a somatostatin

A phase III evaluation of a somatostatin analogue (octreotide) in the treatment of patients with asymptomatic advanced colon carcinoma

✍ Richard M. Goldberg; Charles G. Moertel; Harry S. Wieand; James E. Krook; Allan 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 499 KB 👁 3 views

A phase III evaluation of a somatostatin

A phase III evaluation of a somatostatin analogue (octreotide) in the treatment of patients with asymptomatic advanced colon carcinoma

✍ David L. Morris 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 71 KB 👁 3 views

I of a Somatostatin Analogue (Octreotide) in the Treatment of Patients with Asymptomatic Advanced Colon Cancer."' The disappointing results of this study contrast with recently reported cellular kinetic data for rectal cancer treatment with somatostatin. It should be noted that the dosage used in o